National Research (NASDAQ:NRC) Posts Earnings Results

Key Points

• National Research met earnings expectations, reporting quarterly EPS of $0.21, while revenue of $38.4 million exceeded analysts’ $35.8 million forecast.
• Shares fell 3.1% to $21.75 during Tuesday trading. The stock has a 12-month range of $11.43 to $23.68 and trades at a price-to-earnings ratio of 87.
• Analyst sentiment is mixed, with ratings ranging from buy to sell; the consensus rating is “Hold” and the average price target is $26.00.

National Research (NASDAQ:NRC - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.21, FiscalAI reports. The company had revenue of $38.40 million during the quarter, compared to analysts' expectations of $35.80 million. National Research had a net margin of 4.18% and a return on equity of 164.26%.

National Research Trading Down 3.1%

Shares of NRC stock traded down $0.70 during mid-day trading on Tuesday, reaching $21.75. The company's stock had a trading volume of 105,711 shares, compared to its average volume of 111,171. The company's 50 day simple moving average is $21.12 and its 200-day simple moving average is $19.13. National Research has a 12-month low of $11.43 and a 12-month high of $23.68. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 13.13. The firm has a market capitalization of $494.73 million, a PE ratio of 87.00 and a beta of 0.25.

Analyst Ratings Changes

Several research analysts recently weighed in on NRC shares. Wall Street Zen lowered National Research from a "buy" rating to a "hold" rating in a research report on Saturday, August 15th. Zacks Research upgraded National Research to a "hold" rating in a report on Monday, October 5th. Weiss Ratings downgraded National Research from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, October 9th. Finally, Citizens Jmp upped their price target on National Research from $23.00 to $26.00 and gave the stock a "market outperform" rating in a research note on Wednesday, July 29th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, National Research presently has an average rating of "Hold" and a consensus target price of $26.00.

About National Research

National Research Corporation, formerly traded on the Nasdaq under the symbol NRC, provides research, analytics and performance-improvement services to the health care industry. Through its NRC Health business, the company helps hospitals, health systems and other care organizations understand and improve patient, consumer and employee experiences.

Its offerings have included patient and employee surveys, market research, reputation management, loyalty and engagement programs, benchmarking, and software tools that turn feedback and other data into operational insights.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.